Non-Alcoholic Fatty Liver Background - Viral Hepatitis and Liver Disease
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Viral Hepatitis and Liver Disease

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

Non-Alcoholic Fatty Liver Background

for Health Care Providers

Background - Non-Alcoholic Fatty Liver

Non-alcoholic fatty liver disease (NAFLD) affects nearly 1 in 3 Americans, is increasing in the Veterans Health Administration, and requires action. It is most common in people living with diabetes (40-70%) or obesity (61-95%), with higher rates in older or Hispanic patients. NAFLD independently increases the risk of diabetes (2-5 fold), heart and kidney disease, cirrhosis, liver cancer, and death. It also impairs health-related quality of life.

NAFLD varies in severity. Of all patients living with NAFLD:

  • 65-70% have simple fatty liver (fat accumulation in more than 5% of liver cells).
  • 25-30% have nonalcoholic steatohepatitis (NASH) with liver fat, inflammation, and injury, and elevated levels of alanine aminotransferase (ALT) in the blood.
  • 4% have NAFLD cirrhosis and/or hepatocellular carcinoma.

NAFLD is the most frequent cause of asymptomatic ALT elevations in primary care patients. The condition usually progresses slowly over decades, with greater progression in people living with diabetes or other liver diseases. NAFLD in combination with advanced fibrosis increases mortality and liver-related events, including transplantation.